Clinical Trial Update: Prophylaxis of Fungal Invasive Infections in Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating prophylaxis against invasive fungal infections in leukemia patients, with a focus on invasive pulmonary aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Pulmonary Aspergillosis

Snippet

Sponsor: Northern Italy Leukemia Group | Conditions: Invasive Pulmonary Aspergillosis | Phase 2 | Status: COMPLETED